Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-15

Clinical Trial Update: An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate

View source ↗

Summary

An Italian observational study evaluated outcomes for people with HIV treated with Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide); the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Janssen-Cilag S.p.A. | Conditions: Human Immunodeficiency Virus (HIV) | Status: COMPLETED